JPS63208569A - Production of 4-acetoxy-3-hydroxyethylazetidin-2-one derivative - Google Patents

Production of 4-acetoxy-3-hydroxyethylazetidin-2-one derivative

Info

Publication number
JPS63208569A
JPS63208569A JP62042205A JP4220587A JPS63208569A JP S63208569 A JPS63208569 A JP S63208569A JP 62042205 A JP62042205 A JP 62042205A JP 4220587 A JP4220587 A JP 4220587A JP S63208569 A JPS63208569 A JP S63208569A
Authority
JP
Japan
Prior art keywords
group
compound
manufacturing
formula
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62042205A
Other languages
Japanese (ja)
Other versions
JPH0730016B2 (en
Inventor
Isao Sada
佐田 功
Kazunori Suga
和憲 菅
Noboru Kamiyama
昇 上山
Shingo Matsumoto
慎吾 松本
Takehisa Ohashi
武久 大橋
Kiyoshi Watanabe
清 渡辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Priority to JP62042205A priority Critical patent/JPH0730016B2/en
Priority to CN88100764A priority patent/CN1017991B/en
Priority to IE42488A priority patent/IE60564B1/en
Priority to CA000559047A priority patent/CA1278302C/en
Priority to ES198888102324T priority patent/ES2038704T3/en
Priority to US07/156,873 priority patent/US4914199A/en
Priority to DE8888102324T priority patent/DE3870926D1/en
Priority to EP88102324A priority patent/EP0280962B1/en
Priority to KR1019880001782A priority patent/KR950005913B1/en
Publication of JPS63208569A publication Critical patent/JPS63208569A/en
Publication of JPH0730016B2 publication Critical patent/JPH0730016B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PURPOSE:To obtain the titled compound useful as a synthetic intermediate for carbapenem beta-lactam antibiotic substance and penem beta-lactam antibiotic substance, in high yield, by reacting a beta-lactam compound with a base and acetic anhydride in the presence of a specific catalyst. CONSTITUTION:A beta-lactam compound of formula I (R1 is OH-protecting group; R2-R4 are 1-4C lower alkyl or aralkyl) is made to react with a base (e.g. pyridine) and acetic anhydride using a compound of formula II (R5 is 1-6C lower alkyl or phenyl; X is halogen or CF3SO2O; n is 1-4) as a catalyst to obtain the objective compound of formula III. The reaction is carried out either by using the base as the reaction solvent or in an organic solvent such as dimethylformamide at -30-+50 deg.C. The compound of formula II is e.g. trimethylchlorosilane. The amounts of the compound of formula II, the base and acetic anhydride are 0.05-1mol., 1-30mol. and 1-15mol. per 1mol. of the compound of formula I, respectively.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、3位に水酸基が保護されたヒドロキシエチル
基を有し、4位にアセトキシ基を有する4−アセトキシ
−3−ヒドロキシエチルアゼチジン−2−オン誘導体の
新規な製造法に関する。
Detailed Description of the Invention (Industrial Application Field) The present invention relates to 4-acetoxy-3-hydroxyethylazetidine, which has a hydroxyethyl group with a protected hydroxyl group at the 3-position and an acetoxy group at the 4-position. The present invention relates to a novel method for producing -2-one derivatives.

4−アセトキシ−3−ヒドロキシエチルアゼチジン−2
−オン誘導体は、チェナマイシン等に代表すれるカルバ
ペネム系β−ラクタム抗生物質や、ペネム系β−ラクタ
ム抗生物質の合成中間体として有用であることが知られ
ている〔たとえば、レイダー等、テトラヘドロンレター
ズ、23巻、2293頁(1982)、およびヨシダ等
、ケミカル・アンド・ファーマシュテイカル・ブレチン
(Chem、 Pharm、 Bull、)、29巻、
2899頁(1981))。
4-acetoxy-3-hydroxyethylazetidine-2
-one derivatives are known to be useful as synthetic intermediates for carbapenem β-lactam antibiotics, such as chenamycin, and penem β-lactam antibiotics [for example, Raider, tetrahedron, etc. Letters, Vol. 23, p. 2293 (1982), and Yoshida et al., Chemical and Pharmaceutical Bulletin (Chem, Pharm, Bull), Vol. 29,
2899 pages (1981)).

(従来の技術と問題点) 従来、4−アセトキシ−3−ヒドロキシエチルアゼチジ
ン−2−オン誘導体の合成法として、6−アミノペニシ
ラン酸から合成する方法〔ヨシダ等、Chem、 Ph
arm、 Bu l l 、、 29巻、2899頁(
1981):l、スレオニンから合成する方法〔シオザ
キ等、テトラヘドロン、39巻、2899頁 (198
8)]、アスパラギン酸から合成する方法〔レイダー等
、テトラヘドロンレターズ、23巻、2293頁(19
82)]等が知られている。
(Prior art and problems) Conventionally, a method for synthesizing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives from 6-aminopenicillanic acid [Yoshida et al., Chem, Ph.
arm, Bull, vol. 29, p. 2899 (
1981): Method of synthesis from threonine [Shiozaki et al., Tetrahedron, vol. 39, p. 2899 (198
8)], method of synthesis from aspartic acid [Leider et al., Tetrahedron Letters, Vol. 23, p. 2293 (19
82)] etc. are known.

しかし、いずれの方法においても、β−ラクタム環の4
位にアセトキシ基を導入するために、酢酸水銀や四酢酸
鉛等の工業的には好ましくない重金属化合物を使用する
難点を有していた。
However, in both methods, the β-lactam ring
In order to introduce an acetoxy group into the position, heavy metal compounds such as mercury acetate and lead tetraacetate, which are not suitable for industrial use, are used.

本発明者らは8位に〇−保護ヒドロキシエチル基、4位
にシリルエーテル基を有する新規なβ−ラクタム化合物
(Nは無保護)を用いて、低温で4位にアセトキシ基を
導入する製法を見出し、既に出願した(特願昭6l−1
01856)。
The present inventors have developed a production method in which an acetoxy group is introduced into the 4-position at a low temperature using a novel β-lactam compound having an 0-protected hydroxyethyl group at the 8-position and a silyl ether group at the 4-position (N is unprotected). I have already filed an application (Patent Application No. 6l-1
01856).

その後、本発明者らは更に検討を行なった結果、触媒量
の一般式(1) %式%)(1) (式中、R5はcl−C6の低級アルキル基またはフェ
ニル基を示し、Xはハロゲン基またはaF3so2o基
を示す。n=1〜4)  で表わされる化合物を加える
事により、室温付近において良い収率で4位にアセトキ
シ基を導入する方法を見出し、本発明に至った。以下に
詳細を説明する。
After that, the present inventors conducted further studies and found that the general formula (1) % formula %) (1) (in the formula, R5 represents a lower alkyl group of cl-C6 or a phenyl group, and X represents a catalytic amount) By adding a compound represented by a halogen group or an aF3so2o group (n=1 to 4), a method was discovered to introduce an acetoxy group into the 4-position in a good yield at around room temperature, leading to the present invention. Details will be explained below.

(問題点を解決するための手段及び作用効果)本発明は
、一般式(1) (式中、R1は水酸基の保護基、R2、aa tR4は
C1〜C4の低級アルキル基、またはアラルキル基を示
す)で表わされるβ−ラクタム化合物に、一般式(1) %式%() (式中、R5は01〜C6の低級アルキル基またはフェ
ニル基を示し、Xはハロゲン基またはCF35020基
を示す。n=1〜4)  で表わされる化合物を触媒と
して、塩基と無水酢酸を作用させることを特徴とする、
一般式(III)(式中、R1は水酸基の保護基を示す
)で表わされる4−アセトキシ−3−ヒドロキシエチル
アゼチジン−2−オン誘導体の製造方法を要旨とする。
(Means and Effects for Solving the Problems) The present invention is based on the general formula (1) (wherein, R1 is a hydroxyl protecting group, R2, aa tR4 are C1 to C4 lower alkyl groups, or aralkyl groups). A β-lactam compound represented by the general formula (1) % formula % ( ) (wherein R5 represents a lower alkyl group of 01 to C6 or a phenyl group, and X represents a halogen group or a CF35020 group). n = 1 to 4) as a catalyst, a base and acetic anhydride are allowed to react,
The gist of the present invention is a method for producing a 4-acetoxy-3-hydroxyethylazetidin-2-one derivative represented by the general formula (III) (wherein R1 represents a hydroxyl protecting group).

一般式(1)で示される4位にシリルエーテル基を有す
るβ−ラクタム化合物は本発明者らが既に特許出願(特
開昭6l−18791)したように、反応式Iの方法に
よって簡便に取得できる。
The β-lactam compound having a silyl ether group at the 4-position represented by general formula (1) can be easily obtained by the method of reaction formula I, as the present inventors have already applied for a patent (Japanese Patent Application Laid-Open No. 61-18791). can.

反応式I: β−ラクタム化合物(1)の3位のヒドロキシエチル基
の〇−保護基であるR1 としては、R1が一般式(I
V) Si  R7(IV) (式中、R6+ R7+ R8はC1〜C6の低級アル
キル基を示す。ただし、R6y R7t ag は同時
にC1でない。)で表わされるトリアルキルシリル基、
たとえばtert−ブチルジメチルシリル基、トリイソ
プロピルシリル基、イソプロピルジメチルシリル基、イ
ソブチルジメチルシリル基、ジメチル−(1,2−ジメ
チルプロピル)シリル基、ジメチル−(1,1,2−)
−ジメチルプロピル)シリル基や、その他ter t−
ブチル基、ベンジル基、トリクロロエトキシカルボニル
基、tert−ブトキシカルボニル基、p−ニトロベン
ジルオキシカルボニル基等が誉げられるが、好ましくは
反応中より安定であり、さらに酸処理により選択的に脱
保護されうるtert−ブチルジメチルシリル基やイソ
プロピルジメチルシリル基やジメチル−(1,1゜2−
トリメチルシリル)シリル基及びジメチル−(1,2−
ジメチルプロピル)シリル基がよい。
Reaction formula I: R1 is the 〇-protecting group for the hydroxyethyl group at the 3-position of the β-lactam compound (1), and R1 is represented by the general formula (I
V) a trialkylsilyl group represented by Si R7(IV) (wherein R6+ R7+ R8 represents a C1 to C6 lower alkyl group. However, R6y R7t ag is not C1 at the same time);
For example, tert-butyldimethylsilyl group, triisopropylsilyl group, isopropyldimethylsilyl group, isobutyldimethylsilyl group, dimethyl-(1,2-dimethylpropyl)silyl group, dimethyl-(1,1,2-)
-dimethylpropyl)silyl group and other tert-
A butyl group, a benzyl group, a trichloroethoxycarbonyl group, a tert-butoxycarbonyl group, a p-nitrobenzyloxycarbonyl group, etc. are preferred, but they are preferably stable during the reaction and can be selectively deprotected by acid treatment. tert-butyldimethylsilyl group, isopropyldimethylsilyl group, dimethyl-(1,1゜2-
trimethylsilyl)silyl group and dimethyl-(1,2-
Dimethylpropyl)silyl group is preferable.

また、β−ラクタム化合物(1)のR2t Ra+ R
4は、メチル、エチル、イソブチル等の01〜C4の低
級アルキル基、またはベンジル基、p−ニトロベンジル
基等のアラルキル基から同一または異なった基を選択で
きるが、好ましくはR2=18=R4=メチルが最適で
ある。
Moreover, R2t Ra+ R of β-lactam compound (1)
4 can be selected from the same or different groups from 01 to C4 lower alkyl groups such as methyl, ethyl, isobutyl, or aralkyl groups such as benzyl group and p-nitrobenzyl group, but preferably R2=18=R4= Methyl is the best.

上記のように調製した一般式(1) (式中、R1# R2p RB p R4は前記と同じ
)で表わされるβ−ラクタム化合物に塩基と無水酢酸を
作用させて、目的の4−アセトキシ−3−ヒドロキシエ
チルアゼチジン−2−オン誘導体(III)(式中、R
,は前記と同じ)に変換するのであるが、この際一般式
(II) (Rs )4−n−s 1(X)n(II)(式中、R
5,x、nは前記と同じ)で表わされる化合物を触媒と
して作用させると収率が著しく向上する。
The β-lactam compound represented by the general formula (1) (where R1#R2pRBpR4 is the same as above) prepared as above is reacted with a base and acetic anhydride to obtain the desired 4-acetoxy-3 -Hydroxyethylazetidin-2-one derivative (III) (wherein R
, are the same as above), but at this time, the general formula (II) (Rs )4-n-s 1(X)n(II) (where R
When a compound represented by (5, x, n are the same as above) acts as a catalyst, the yield is significantly improved.

一般式(N)で表わされる化合物としては、トリメチル
シリルトリフルオロメタンスルホネートのほか、トリメ
チルハロシラン、トリエチルハロシラン、トリイソプロ
ピルハロシラン、トリプロピルハロシラン、トリフェニ
ルハロシラン、ジフェニルメチルハロシラン、 ter
t −ブチルジフェニルハロシラン、 tert−ブチ
ルジメチルハロシラン、イソブチルジメチルハロシラン
、イソプロピルジメチルハロシラン、ジメチル−(1,
1,2−トリメチルプロピル)ハロシラン、ジメチル−
(l。
Examples of the compound represented by the general formula (N) include trimethylsilyltrifluoromethanesulfonate, trimethylhalosilane, triethylhalosilane, triisopropylhalosilane, tripropylhalosilane, triphenylhalosilane, diphenylmethylhalosilane, ter
t-Butyldiphenylhalosilane, tert-butyldimethylhalosilane, isobutyldimethylhalosilane, isopropyldimethylhalosilane, dimethyl-(1,
1,2-trimethylpropyl)halosilane, dimethyl-
(l.

2−ジメチルプロピル)ハロシラン、 tert−ブチ
ルメチルフェニルハロシラン等、またはジメチルジハロ
シラン、ジフェニルジハロシラン、メチルプロピルジハ
ロシラン等、またはメチルトリハロシラン、エチルトリ
ハロシラン、プロピルトリハロシラン、ブチルトリハロ
シラン等、またはテトラクロルシラン等が使用できる。
2-dimethylpropyl)halosilane, tert-butylmethylphenylhalosilane, etc., or dimethyldihalosilane, diphenyldihalosilane, methylpropyldihalosilane, etc., or methyltrihalosilane, ethyltrihalosilane, propyltrihalosilane, butyltrihalosilane etc., or tetrachlorosilane, etc. can be used.

上記の化合物(1)を添加せずに、塩基と無水酢酸で化
合物(1)をアセトキシ化すると、β−ラクタム環が開
裂した分解物が反応生成物として大部分であり、目的の
化合物(I)を満足すべき収率で得ることができない。
When compound (1) is acetoxylated with a base and acetic anhydride without adding the above compound (1), most of the reaction products are decomposition products in which the β-lactam ring is cleaved, and the target compound (I ) cannot be obtained in a satisfactory yield.

一般式(1)で表わされるこれらの化合物の存在下での
化合物(1)の4位アセトキシ化においては、化合物(
I)と塩基と無水酢酸の使用量、溶媒、塩基の種類及び
反応温度が収率に影響を与える因子である。塩基として
はピリジン、ピコリン、ルチジン等のピリジン類が好ま
しい。反応溶媒としては上記の塩基を溶媒として使用す
るか、あるいは化合物(1)や反応試剤に不活性な有機
溶媒、例えば塩化メチレン、酢酸エチル、n−ヘキサン
、トルエン、ジメチルホルムアミド、テトラヒドロフラ
ン等が使用できるが、好ましくはピリジン類またはジメ
チルホルムアミドを使用するのがよい。
In the 4-position acetoxylation of compound (1) in the presence of these compounds represented by general formula (1), compound (
I), the amount of base and acetic anhydride used, the solvent, the type of base, and the reaction temperature are factors that affect the yield. As the base, pyridines such as pyridine, picoline, and lutidine are preferred. As the reaction solvent, the base mentioned above can be used as a solvent, or an organic solvent inert to compound (1) and the reaction reagent, such as methylene chloride, ethyl acetate, n-hexane, toluene, dimethylformamide, tetrahydrofuran, etc. can be used. However, it is preferable to use pyridines or dimethylformamide.

一般式(1)で表わされるβ−ラクタム化合物に対し、
一般式(II)で表わされる化合物を0.05〜1倍モ
ル、塩基を1〜30倍モル、無水酢酸は1〜15倍モル
の範囲で使用すればよい。反応温度は−8()−4−)
50℃の範囲が好ましい。
For the β-lactam compound represented by general formula (1),
The compound represented by general formula (II) may be used in an amount of 0.05 to 1 mole, the base in a 1 to 30 mole amount, and acetic anhydride in a 1 to 15 mole amount. The reaction temperature is -8()-4-)
A range of 50°C is preferred.

反応操作としては、ピリジン等の塩基単独、あるいはジ
メチルホルムアミド等の溶媒とピリジン等の塩基との混
合溶媒に一般式(1)で示される4位にシリルエーテル
基を有するβ−ラクタム化合物を溶解し、次に無水酢酸
及び一般式(1)で表わされる化合物を一度に、あるい
は分割して加えて反応を行なう。反応経過を薄層クロマ
トグラフィーでチェックしながら実施し、原料が消失ま
たは微量になったところで水へ反応液を注ぐ。次にn−
ヘキサン等の有機溶媒で抽出を行なう。有機層を炭酸水
素ナトリウム水溶液、水で洗浄した後、無水硫酸マグネ
シウムで乾燥する。溶媒を留去して得られた粗結晶をn
−ヘキサン等の溶媒で再結晶することにより目的の4−
アセトキシ−3−ヒドロキシエチルアゼチジン−2−オ
ン誘導体を得る。n−ヘキサンを抽出溶媒に用いた場合
には、乾燥後、溶液を冷却して4−アセトキシ−3−ヒ
ドロキシエチルアゼチジン−2−オン誘導体を結晶とし
て得ることもできる。そのほか、溶媒を留去した反応混
合物からカラムクロマトグラフィーにより4−アセトキ
シ−3−ヒドロキシエチルアゼチジン−2−オン誘導体
を得ることもできる。
For the reaction operation, a β-lactam compound having a silyl ether group at the 4-position represented by general formula (1) is dissolved in a base such as pyridine alone or a mixed solvent of a solvent such as dimethylformamide and a base such as pyridine. Then, acetic anhydride and the compound represented by the general formula (1) are added all at once or in portions to carry out the reaction. The progress of the reaction is checked using thin layer chromatography, and when the raw materials have disappeared or become trace amounts, the reaction solution is poured into water. Then n-
Extraction is performed with an organic solvent such as hexane. The organic layer is washed with an aqueous sodium bicarbonate solution and water, and then dried over anhydrous magnesium sulfate. The crude crystals obtained by distilling off the solvent were
- By recrystallizing with a solvent such as hexane, the desired 4-
An acetoxy-3-hydroxyethylazetidin-2-one derivative is obtained. When n-hexane is used as the extraction solvent, the 4-acetoxy-3-hydroxyethylazetidin-2-one derivative can also be obtained as a crystal by cooling the solution after drying. In addition, a 4-acetoxy-3-hydroxyethylazetidin-2-one derivative can also be obtained by column chromatography from the reaction mixture after distilling off the solvent.

((実施例) 以下実施例で本発明の詳細な説明するが、これらの実施
例によって本発明が限定されるものではない。
(Examples) The present invention will be explained in detail below using Examples, but the present invention is not limited to these Examples.

実施例1 (SR,4R)−4−アセトキシ−3−C(R)−l 
−tert−ブチルジメチルシリロキシエチル〕アゼチ
ジン−2−オンの合成 (8R,4几)−8−C(R)−tert−ブチルジメ
チルシリロキシエチル〕−4−トリメチルシリロキシア
ゼチジン−2−オンCmp 95〜96℃。
Example 1 (SR,4R)-4-acetoxy-3-C(R)-l
Synthesis of -tert-butyldimethylsilyloxyethyl]azetidin-2-one (8R, 4 liters) -8-C(R)-tert-butyldimethylsilyloxyethyl]-4-trimethylsilyloxyazetidin-2-one Cmp 95-96°C.

Iをピリジン7、6 mJに溶解し、窒素雰囲気下、無
水酢酸2.5ml!、)リメチルクロルシラン0.12
m1!を加え、9℃で41時間撹拌した。反応液を水1
50m/中に注ぎ、n−ヘキサン150m1!で抽出し
た。有機層をさらに5%NaHOO3,飽和食塩水で洗
浄後、無水硫酸マグネシウムで乾燥した。F別後、溶媒
を減圧留去して白色固体1.250.9  を得た。こ
の白色固体の一部1.000.9をn−ヘキサンに溶解
し、不溶物戸去後−15℃で冷却放置することにより6
90m、9の針状結晶が得られ、以下の物性値から目的
とする(3R24R)−4−アセトキシ−8−C(R)
−1−tert−ブチルジメチルシリロキシエチル〕ア
ゼチジン−2−オンであることが確認された。
Dissolve I in 7.6 mJ of pyridine and add 2.5 ml of acetic anhydride under nitrogen atmosphere! ,) Limethylchlorosilane 0.12
m1! was added and stirred at 9°C for 41 hours. Add the reaction solution to 1 part water
Pour into 50m/150ml of n-hexane! Extracted with. The organic layer was further washed with 5% NaHOO3 and saturated brine, and then dried over anhydrous magnesium sulfate. After separating F, the solvent was distilled off under reduced pressure to obtain 1.250.9 of a white solid. A part of 1.000.9 of this white solid was dissolved in n-hexane, and after removing the insoluble matter, it was left to cool at -15°C.
A needle-shaped crystal of 90m, 9 was obtained, and the desired (3R24R)-4-acetoxy-8-C(R) was obtained from the following physical properties.
It was confirmed that it was -1-tert-butyldimethylsilyloxyethyl]azetidin-2-one.

〔α〕  +50°(CO,5、CHCl8)mp10
7℃ ’HNMR(90MHz、CDC1a)  δ(ppm
)0.08(6H,S)、  0.84(9H,S)。
[α] +50° (CO, 5, CHCl8) mp10
7℃ 'HNMR (90MHz, CDC1a) δ (ppm
) 0.08 (6H, S), 0.84 (9H, S).

1.20(8H,d)、  2.01(8H,s)。1.20 (8H, d), 2.01 (8H, s).

8.04(LH,dd)、4.12(IH,m)。8.04 (LH, dd), 4.12 (IH, m).

5.76(IH,d)、  6.73(Nu)また上記
白色固体の一部を高速液体クロマトグラフィー〔カラム
YMO−バツクドカラムA −808(ODS)、4.
6x250mm、カラム温度15℃、溶媒アセトニトリ
ル:水= 6 : 4 (r)。
5.76 (IH, d), 6.73 (Nu) A part of the above white solid was also subjected to high performance liquid chromatography [column YMO-backed column A-808 (ODS), 4.
6x250 mm, column temperature 15°C, solvent acetonitrile:water = 6:4 (r).

流量1.1 rnI!/nl 1 n 、検出210n
m〕で分析すると、全体で1.014JFの(8R,4
R)−4−アセトキシ−8−C(R)−1−tert−
ブチルジメチルシリロキシエチル〕アゼチジン−2−オ
ンが生成していた(収率74%)。
Flow rate 1.1 rnI! /nl 1 n, detection 210n
m], a total of 1.014JF (8R,4
R)-4-acetoxy-8-C(R)-1-tert-
Butyldimethylsilyloxyethyl]azetidin-2-one was produced (yield 74%).

実施例2 (3R,4R)−4−アセトキシ−3−C(R)−l 
−tert−ブチルジメチルシリロキシエチル〕アゼチ
ジン−2−オンの合成 (3几、 4R)−3−C(R)−1−tert−ブチ
ルジメチルシリロキシエチル]−4−トリメチルシリロ
キシアゼチジン−2−オン 302m、9を塩化メチレ
ン0.74 ml!に溶解し、ピリジン0.77m1.
無水酢酸0.27 ml!を加えた後、窒素雰囲気下、
トリメチルクロルシラン0.012m1!を加え、室温
で17時間撹拌した。反応液を水80m1!中に注ぎ、
n−ヘキサン80m/で抽出した。有機層をさらに5%
NaHCOa 、  飽和食塩水で洗浄後、無水硫酸マ
グネシウムで乾燥した。
Example 2 (3R,4R)-4-acetoxy-3-C(R)-l
Synthesis of -tert-butyldimethylsilyloxyethyl]azetidin-2-one (3 liters, 4R) -3-C(R)-1-tert-butyldimethylsilyloxyethyl]-4-trimethylsilyloxyazetidine-2 -on 302m, 9 with methylene chloride 0.74 ml! Dissolve in 0.77 ml of pyridine.
0.27 ml of acetic anhydride! After adding, under nitrogen atmosphere,
Trimethylchlorosilane 0.012ml! was added and stirred at room temperature for 17 hours. Add the reaction solution to 80ml of water! Pour it inside;
Extracted with 80 m/n-hexane. Add 5% more organic layer
After washing with NaHCOa and saturated brine, it was dried over anhydrous magnesium sulfate.

F別後、溶媒を減圧留去して白色固体262m、Fを得
た。この固体を高速液体クロマトグラフィーで分析した
ところ(3R2□4B)−4−アセトキシ−8−C(R
) −1−tert−ブチルジメチルシリロキシエチル
〕アゼチジン−2−オンが98r#生成していた(収率
36%)。
After separating F, the solvent was distilled off under reduced pressure to obtain 262m of F as a white solid. This solid was analyzed by high performance liquid chromatography (3R2□4B)-4-acetoxy-8-C(R
) 98r# of -1-tert-butyldimethylsilyloxyethyl]azetidin-2-one was produced (yield 36%).

実施例3 (8R,4R)−4−アセトキシ−8−[:(R)−1
−tert−ブチルジメチルシリロキシエチル〕アゼチ
ジン−2−オンの合成 実施例1と同様な方法によって、化合物(II)を種々
変化させる実験を実施した。化合物(II)を添加しな
い条件も比較のため実験を行なった。化合物(r)に対
して無水酢酸5.6当量、ピリジン19.7当量を用い
、処理及び分析条件は実施例1と同様である。結果を表
1に示した。
Example 3 (8R,4R)-4-acetoxy-8-[:(R)-1
Synthesis of -tert-butyldimethylsilyloxyethyl]azetidin-2-one In the same manner as in Example 1, experiments were carried out in which Compound (II) was varied in various ways. For comparison, an experiment was also conducted under conditions in which Compound (II) was not added. The treatment and analysis conditions were the same as in Example 1, using 5.6 equivalents of acetic anhydride and 19.7 equivalents of pyridine with respect to compound (r). The results are shown in Table 1.

(1’)          (II’)表1 実施例4 (IR,4R)−4−アセトキシ−8−C(R)−1−
tert−ブチルジメチルシリロキシエチル〕アゼチジ
ン−2−オンの合成 実施例1と同様な方法によって、塩基を変化させる実験
を実施した。化合物(r)に対して無水酢酸5.6当量
、トリメチルクロルシラン0.2当fiを用い、処理及
び分析条件は実施例1と同様である。
(1') (II') Table 1 Example 4 (IR,4R)-4-acetoxy-8-C(R)-1-
Synthesis of tert-butyldimethylsilyloxyethyl]azetidin-2-one An experiment was conducted in which the base was changed in the same manner as in Example 1. The treatment and analysis conditions were the same as in Example 1, using 5.6 equivalents of acetic anhydride and 0.2 equivalents of trimethylchlorosilane with respect to compound (r).

結果を表2に示した。The results are shown in Table 2.

表2 実施例5 (3・几、4R)−4−アセトキシ−3−[: (R)
−1−〔ジメチル−(1,1,2−トリメチルプロピル
)シリロキシ〕エチル〕アゼチジン−2−オンの合成 (8R,4R)−+3−C(R)−1−(ニジメチル−
(1,1,2−トリメチルプロピル)シリロキシ〕エチ
ル)−4−トリメチルシリロキシアゼチジン−2−オン
520m、9をピリジン2.44 ml!に溶解し、窒
素雰囲気下9℃に冷却した。ついで無水酢酸0.81m
1!、トリメチルクロルシラン0.039m1!を加え
、9℃で40時間撹拌した。反応後、実施例1と同様の
方法で処理し、401m、9のセミソリッドを得た。こ
のものをシリカゲルカラム〔n−ヘキサン:酢酸エチル
: l O: 1 、(V/V):1で処理し、目的と
する(8R,5R)−4−アセトキシ−8−[:(R)
−1−(ニジメチル−(1,1,2−トリメチルプロピ
ル)シリロキシ〕エチル〕アゼチジン−2−オン838
mIiを白色針状結晶として得た。物性値を以下に示す
Table 2 Example 5 (3・几,4R)-4-acetoxy-3-[: (R)
Synthesis of -1-[dimethyl-(1,1,2-trimethylpropyl)silyloxy]ethyl]azetidin-2-one (8R,4R)-+3-C(R)-1-(nidimethyl-
(1,1,2-trimethylpropyl)silyloxy]ethyl)-4-trimethylsilyloxyazetidin-2-one 520ml, 9 in pyridine 2.44ml! and cooled to 9° C. under nitrogen atmosphere. Then 0.81 m of acetic anhydride
1! , trimethylchlorosilane 0.039ml! was added and stirred at 9°C for 40 hours. After the reaction, it was treated in the same manner as in Example 1 to obtain 401m, 9 semi-solid. This product was treated with a silica gel column [n-hexane:ethyl acetate: 1 O: 1, (V/V): 1] to obtain the desired (8R,5R)-4-acetoxy-8-[:(R)
-1-(nidimethyl-(1,1,2-trimethylpropyl)silyloxy]ethyl]azetidin-2-one 838
mIi was obtained as white needle-like crystals. The physical property values are shown below.

〔α]   +41.5° (CO,5、CHCl3)
mpso〜81℃ IHNMR(90MHz  、CDOI B )  δ
(ppm)0.08(6H,s)、  0.75(6H
,s)。
[α] +41.5° (CO,5, CHCl3)
mpso~81℃ IHNMR (90MHz, CDOIB) δ
(ppm) 0.08 (6H, s), 0.75 (6H
,s).

0.88(6H,d)、  1.20(8H,d)。0.88 (6H, d), 1.20 (8H, d).

1.50(IH,m)、  2.00(3H,s)。1.50 (IH, m), 2.00 (3H, s).

3.10(IH,dd)、4.12(IH,m)。3.10 (IH, dd), 4.12 (IH, m).

5.75(LH,d)、  6.5L(NEI)実施例
6 (8R,4R)−4−アセトキシ−8−C(R)−1−
イソプロピルジメチルシリロキシエチル〕アゼチジン−
2−オンの合成 (:(R,4R)−8−((R)−1−イソプロピルジ
メチルシリロキシエチル〕−4−トリメチルシリロキシ
アゼチジン−2−オン801 m、9をピリジン1.5
8 mlに溶解し、窒素雰囲気下9℃に冷却した。つい
で無水酢酸0.52m1!、トリメチルクロルシラン0
.025m1!を加え、9℃で40時間撹拌した。反応
後、実施例1と同様の方法で処理し、229mJのセミ
ソリッドを得た。このものをシリカゲルカラム〔n−ヘ
キサン:酢酸エチル= 10 : 1 、 (v/v)
]で処理し、目的とする(3R,4R)−4−アセトキ
シ−3−C(R)−1−イソプロピルジメチルシリロキ
シエチル〕アゼチジン−2−オン176 mlを白色結
晶として得た。物性値を以下に示す。
5.75(LH,d), 6.5L(NEI) Example 6 (8R,4R)-4-acetoxy-8-C(R)-1-
Isopropyldimethylsilyloxyethyl]azetidine-
Synthesis of 2-one (:(R,4R)-8-((R)-1-isopropyldimethylsilyloxyethyl)-4-trimethylsilyloxyazetidin-2-one 801 m, 9 with pyridine 1.5
The solution was dissolved in 8 ml and cooled to 9°C under nitrogen atmosphere. Next, 0.52ml of acetic anhydride! , trimethylchlorosilane 0
.. 025m1! was added and stirred at 9°C for 40 hours. After the reaction, it was treated in the same manner as in Example 1 to obtain a semi-solid of 229 mJ. This was applied to a silica gel column [n-hexane:ethyl acetate = 10:1, (v/v)
] to obtain 176 ml of the desired (3R,4R)-4-acetoxy-3-C(R)-1-isopropyldimethylsilyloxyethyl]azetidin-2-one as white crystals. The physical property values are shown below.

Ca)   +54.6°(CO,5,CHCl3)m
I)   92〜94℃ ’HNMR(90MHz 、 CD01 g ) ’δ
(pI)m)0.08(6H,s)、  1.75(I
H,m)。
Ca) +54.6°(CO,5,CHCl3)m
I) 92-94°C 'HNMR (90MHz, CD01g)'δ
(pI)m) 0.08(6H,s), 1.75(I
H, m).

1.98(6H,d)、  1.29(aH,d)。1.98 (6H, d), 1.29 (aH, d).

2.12(8H,s)、  3.20(IH,dd)。2.12 (8H, s), 3.20 (IH, dd).

4.28(IH,m)、  5.86(IH,d)。4.28 (IH, m), 5.86 (IH, d).

6.50(NH) 実施例7 4−アセトキシ−8−(1−[ニジメチル−(1゜2−
ジメチルプロピル)シリロキシ〕エチル〕アゼチジン−
2−オンの合成 a−[” 1−1ニジメチル−(1,2−ジメチルプロ
ピル)シリロキシ〕エチル]−4−トリメチルシクロキ
シアゼチジン−2−オンaoom、yをピリジン1.4
7m1!に溶解し、窒素雰囲気下9℃に冷却した。つい
で無水酢酸0.49mj’、トリメチルクロルシラン0
.023m1!を加え、9℃で40時間撹拌した。反応
後、実施例1と同様の方法で処理し、201m、9のセ
ミソリッドを得た。このものをシリカゲルカラム〔n−
ヘキサン:酢酸エチル=10:1.(v/v)〕で処理
し、目的とする4−アセトキシ−3−[:1−(ジメチ
ル−(1,2−ジメチルプロピル)シリロキシ〕エチル
〕アゼチジン−2−オン175m、9を白色固体として
得た。
6.50(NH) Example 7 4-acetoxy-8-(1-[nidimethyl-(1°2-
dimethylpropyl)silyloxy]ethyl]azetidine-
Synthesis of 2-one a-[''1-1 dimethyl-(1,2-dimethylpropyl)silyloxy]ethyl]-4-trimethylcycloxyazetidin-2-one aoom, y as pyridine 1.4
7m1! and cooled to 9° C. under nitrogen atmosphere. Then 0.49 mj' of acetic anhydride, 0 of trimethylchlorosilane
.. 023m1! was added and stirred at 9°C for 40 hours. After the reaction, it was treated in the same manner as in Example 1 to obtain a 201m, 9 semi-solid. This product was added to a silica gel column [n-
Hexane:ethyl acetate=10:1. (v/v)] to obtain the desired 4-acetoxy-3-[:1-(dimethyl-(1,2-dimethylpropyl)silyloxy]ethyl]azetidin-2-one 175m, 9 as a white solid. Obtained.

物性値を以下に示す。The physical property values are shown below.

’HNMR(90MHz 、 CDCIg )δ(1)
I)m)0.08(6H,S)、  o、7o(in、
m)。
'HNMR (90MHz, CDCIg) δ(1)
I) m) 0.08 (6H, S), o, 7o (in,
m).

0.85(9H,d、d、d)、1.20(3H,d’
)。
0.85 (9H, d, d, d), 1.20 (3H, d'
).

1.80(IH,m)、  2.02(8H,S)。1.80 (IH, m), 2.02 (8H, S).

3.10(IH,dd)、4.15(IH,m)。3.10 (IH, dd), 4.15 (IH, m).

Claims (12)

【特許請求の範囲】[Claims] (1)一般式( I ) ▲数式、化学式、表等があります▼( I ) (式中、R_1は水酸基の保護基、R_2、R_3、R
_4はC_1〜C_4の低級アルキル基、またはアラル
キル基を示す)で表わされるβ−ラクタム化合物に、一
般式(II) (R_5)_4_−_n−Si(X)_n (II)(式
中、R_5はC_1〜C_6の低級アルキル基またはフ
ェニル基を示し、Xはハロゲン基またはCF_3SO_
2O基を示す。n=1〜4)で表わされる化合物を触媒
として、塩基と無水酢酸を作用させることを特徴とする
、一般式(III)▲数式、化学式、表等があります▼(
III) (式中、R_1は水酸基の保護基を示す)で表わされる
4−アセトキシ−3−ヒドロキシエチルアゼチジン−2
−オン誘導体の製造方法。
(1) General formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) (In the formula, R_1 is a hydroxyl protecting group, R_2, R_3, R
_4 represents a lower alkyl group or an aralkyl group of C_1 to C_4). represents a C_1 to C_6 lower alkyl group or phenyl group, and X is a halogen group or CF_3SO_
Indicates 2O group. The general formula (III) is characterized by the action of a base and acetic anhydride using a compound represented by n=1 to 4) as a catalyst. There are mathematical formulas, chemical formulas, tables, etc.
III) 4-acetoxy-3-hydroxyethylazetidine-2 represented by (wherein R_1 represents a hydroxyl protecting group)
-Method for producing one derivative.
(2)R_1が一般式(IV) ▲数式、化学式、表等があります▼(IV) (式中、R_6、R_7、R_8はC_1〜C_6の低
級アルキル基を示す。ただし、R_6、R_7、R_8
は同時にC_1でない。)である特許請求の範囲第1項
記載の製造方法。
(2) R_1 is the general formula (IV) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (IV) (In the formula, R_6, R_7, R_8 represent lower alkyl groups of C_1 to C_6. However, R_6, R_7, R_8
is not C_1 at the same time. ) The manufacturing method according to claim 1.
(3)R_1がtert−ブチルジメチルシリル基であ
る特許請求の範囲第1項記載の製造方法。
(3) The manufacturing method according to claim 1, wherein R_1 is a tert-butyldimethylsilyl group.
(4)R_1がイソプロピルジメチルシリル基である特
許請求の範囲第1項記載の製造方法。
(4) The manufacturing method according to claim 1, wherein R_1 is an isopropyldimethylsilyl group.
(5)R_1がジメチル−(1,1,2−トリメチルプ
ロピル)シリル基である特許請求の範囲第1項記載の製
造方法。
(5) The manufacturing method according to claim 1, wherein R_1 is a dimethyl-(1,1,2-trimethylpropyl)silyl group.
(6)R_1がジメチル−(1,2−ジメチルプロピル
)シリル基である特許請求の範囲第1項記載の製造方法
(6) The manufacturing method according to claim 1, wherein R_1 is a dimethyl-(1,2-dimethylpropyl)silyl group.
(7)R_2、R_3、R_4がメチル基である特許請
求の範囲第1項記載の製造方法。
(7) The manufacturing method according to claim 1, wherein R_2, R_3, and R_4 are methyl groups.
(8)一般式(II)で表わされる化合物がトリメチルク
ロルシランである特許請求の範囲第1項または第2項記
載の製造方法。
(8) The manufacturing method according to claim 1 or 2, wherein the compound represented by general formula (II) is trimethylchlorosilane.
(9)一般式(II)で表わされる化合物がトリメチルヨ
ードシランである特許請求の範囲第1項または第2項記
載の製造方法。
(9) The manufacturing method according to claim 1 or 2, wherein the compound represented by general formula (II) is trimethyliodosilane.
(10)一般式(II)で表わされる化合物がトリメチル
シリルトリフルオロメタンスルホネートである特許請求
の範囲第1項または第2項記載の製造方法。
(10) The manufacturing method according to claim 1 or 2, wherein the compound represented by general formula (II) is trimethylsilyltrifluoromethanesulfonate.
(11)塩基がピリジンである特許請求の範囲第1項ま
たは第2項記載の製造方法。
(11) The manufacturing method according to claim 1 or 2, wherein the base is pyridine.
(12)塩基がピコリンである特許請求の範囲第1項ま
たは第2項記載の製造方法。
(12) The manufacturing method according to claim 1 or 2, wherein the base is picoline.
JP62042205A 1987-02-20 1987-02-25 Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative Expired - Fee Related JPH0730016B2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP62042205A JPH0730016B2 (en) 1987-02-25 1987-02-25 Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
CN88100764A CN1017991B (en) 1987-02-20 1988-02-15 Process for preparing 4-acetyloxy-3-hydroxyethyl azacyclo-butan-2-one derivatives
IE42488A IE60564B1 (en) 1987-02-20 1988-02-16 Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
CA000559047A CA1278302C (en) 1987-02-20 1988-02-16 Process for preparing 4-acetoxy-3- hydroxyethylazetidin-2-one derivatives
ES198888102324T ES2038704T3 (en) 1987-02-20 1988-02-18 A PROCEDURE FOR PREPARING A DERIVATIVE OF 4-ACETOXI-3-HIDROXIETILAZETIDIN-2-ONA.
US07/156,873 US4914199A (en) 1987-02-20 1988-02-18 Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
DE8888102324T DE3870926D1 (en) 1987-02-20 1988-02-18 METHOD FOR PRODUCING 4-ACETOXY-3-HYDROXYETHYLAZETIDINE-2-ON DERIVATIVES.
EP88102324A EP0280962B1 (en) 1987-02-20 1988-02-18 Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
KR1019880001782A KR950005913B1 (en) 1987-02-20 1988-02-20 Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62042205A JPH0730016B2 (en) 1987-02-25 1987-02-25 Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative

Publications (2)

Publication Number Publication Date
JPS63208569A true JPS63208569A (en) 1988-08-30
JPH0730016B2 JPH0730016B2 (en) 1995-04-05

Family

ID=12629507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62042205A Expired - Fee Related JPH0730016B2 (en) 1987-02-20 1987-02-25 Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative

Country Status (1)

Country Link
JP (1) JPH0730016B2 (en)

Also Published As

Publication number Publication date
JPH0730016B2 (en) 1995-04-05

Similar Documents

Publication Publication Date Title
US4914200A (en) Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
JPH0780884B2 (en) Thienamycin synthetic intermediate and method for producing the same
CA1256443A (en) Process for preparing 4-acetoxy-3- hydroxyethylazetidin-2-one derivatives
Maciejewski et al. An approach to carbapenems from α, β-unsaturated sugar lactones
JPH066570B2 (en) Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
EP0280962B1 (en) Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
JPS63208569A (en) Production of 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
JPH0479333B2 (en)
JPS62252786A (en) 4-substituted beta-lactam compound
JPS62195359A (en) Production of 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
JP2652047B2 (en) Method for producing 4-benzoyloxy-3-hydroxyethylazetidin-2-one derivative
JPH0167A (en) Method for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
KR910003612B1 (en) Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
JPH0557264B2 (en)
US4861877A (en) Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
KR950005913B1 (en) Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
JPH0830057B2 (en) Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
JP3388874B2 (en) Method for producing β-lactam compound
JP2604794B2 (en) Method for producing 4-acetoxy-3-hydroxyethylazetidin-2-one
JPH0655717B2 (en) Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
JPS62164689A (en) Novel beta-lactam compound and production thereof
JPH03236371A (en) (3s)-2-azetidinone derivative and production thereof
JPH01172393A (en) Novel beta-lactam compound and production thereof
JPH05500210A (en) How to make penem
JPH05239020A (en) Production of 3-(r)-1-(substituted-oxycarbonyloxy) ethyl)-4-substituted-2-azetidinone

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees